secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vaxcyte, Inc. (PCVX)
CIK:        0001649094
Form:       8-K
Filed at:   2026-06-23T20:09:09+00:00
Accession:  0001649094-26-000026
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Vaxcyte director Jacks Lee retires; Moncef Slaoui appointed to board
--------------------------------------------------------------------

- Jacks Lee retired from the Board effective June 17, 2026; no disagreement with the company.
- Lee entered a consulting agreement for global strategic supply and manufacturing operations.
- Moncef Slaoui appointed as Class II director effective June 17, 2026; term expires at 2028 annual meeting.
- Slaoui deemed independent under Nasdaq rules; will receive standard non-employee director compensation with annual equity grant valued at $430,000.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1649094/000164909426000026/0001649094-26-000026-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1649094/000164909426000026/pcvx-20260617.htm
  HTML page:      https://secwatch.observer/filing/0001649094-26-000026

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer